​

Bio-Techne (TECH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

TECH Stock Forecast

Bio-Techne (TECH) stock forecast, based on 23 Wall Street analysts, predicts a 12-month average price target of $74.00, with a high of $75.00 and a low of $73.00. This represents a 39.07% increase from the last price of $53.21.

$50 $57 $64 $71 $78 $85 High: $75 Avg: $74 Low: $73 Last Closed Price: $53.21

TECH Stock Rating

Bio-Techne stock's rating consensus is Buy, based on 23 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 16 Buy (69.57%), 7 Hold (30.43%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 23 0 7 16 Strong Sell Sell Hold Buy Strong Buy

TECH Price Target Upside V Benchmarks

TypeNameUpside
StockBio-Techne39.07%
SectorHealthcare Stocks 13.55%
IndustryBiotech Stocks 49.00%

Price Target Trends

1M3M12M
# Anlaysts114
Avg Price Target$73.00$73.00$78.00
Last Closing Price$53.21$53.21$53.21
Upside/Downside37.19%37.19%46.59%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 251114--16
Aug, 252105--17
Jul, 25385--16
Jun, 25385--16
May, 25285--15
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 02, 2025Conor McNamaraRBC Capital$73.00$53.4236.65%37.19%
Mar 17, 2025Evercore ISI$75.00$62.5819.85%40.95%
Oct 31, 2024Catherine SchulteRobert W. Baird$84.00$76.0210.50%57.87%
Oct 30, 2024Paul KnightKeyBanc$80.00$76.025.24%50.35%
Aug 16, 2024Sung Ji NamScotiabank$83.00$74.1911.87%55.99%
Dec 14, 2022Deutsche Bank$100.00$86.9814.97%87.93%
Dec 12, 2022Citigroup$100.00$80.7323.87%87.93%
Dec 07, 2022RBC Capital$89.00$80.6710.33%67.26%
Dec 05, 2022Stephens$105.00$82.4427.37%97.33%
May 05, 2022Paul KnightKeyBanc$125.00$98.9626.31%134.92%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 02, 2025RBC CapitalSector PerformOutperformupgrade
Oct 30, 2024KeyBancOverweightOverweighthold
Aug 16, 2024ScotiabankSector OutperformSector Outperformhold
Aug 13, 2024RBC CapitalSector PerformSector Performhold
May 22, 2024Deutsche BankBuyBuyhold
May 22, 2024CitigroupBuyNeutraldowngrade
May 02, 2024ScotiabankOutperformOutperformhold
Feb 02, 2024RBC CapitalSector PerformSector Performhold
Aug 28, 2023William BlairOutperforminitialise
Dec 14, 2022Deutsche BankBuyinitialise

Financial Forecast

EPS Forecast

Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28
Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28
Reported$0.91$1.73$1.81$1.07----
Avg Forecast$1.64$1.98$2.00$1.78$1.88$2.18$2.49-
High Forecast$1.66$2.01$2.05$1.80$1.92$2.35$2.80-
Low Forecast$1.61$1.94$1.96$1.76$1.83$2.04$2.28-
Surprise %-44.51%-12.63%-9.50%-39.89%----

Revenue Forecast

$900M $1B $1B $2B $2B $2B Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28
Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28
Reported$931.03M$1.11B$1.14B$1.16B----
Avg Forecast$924.08M$1.10B$1.14B$1.16B$1.22B$1.33B$1.48B$1.86B
High Forecast$934.77M$1.12B$1.16B$1.18B$1.23B$1.36B$1.48B$1.89B
Low Forecast$909.11M$1.09B$1.12B$1.14B$1.21B$1.31B$1.47B$1.83B
Surprise %0.75%0.05%-0.54%0.02%----

Net Income Forecast

Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28
Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28
Reported$140.41M$272.05M$285.26M$168.10M----
Avg Forecast$128.87M$196.47M$321.71M$150.68M$300.71M$352.85M$408.30M-
High Forecast$154.64M$235.76M$329.07M$180.82M$308.01M$377.54M$450.83M-
Low Forecast$103.09M$157.18M$315.03M$120.54M$293.42M$328.15M$365.77M-
Surprise %8.96%38.47%-11.33%11.56%----

TECH Forecast FAQ

Is Bio-Techne stock a buy?

Bio-Techne stock has a consensus rating of Buy, based on 23 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 16 Buy, 7 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Bio-Techne is a favorable investment for most analysts.

What is Bio-Techne's price target?

Bio-Techne's price target, set by 23 Wall Street analysts, averages $74 over the next 12 months. The price target range spans from $73 at the low end to $75 at the high end, suggesting a potential 39.07% change from the previous closing price of $53.21.

How does Bio-Techne stock forecast compare to its benchmarks?

Bio-Techne's stock forecast shows a 39.07% upside, outperforming the average forecast for the healthcare stocks sector (13.55%) and underperforming the biotech stocks industry (49.00%).

What is the breakdown of analyst ratings for Bio-Techne over the past three months?

  • September 2025: 6.25% Strong Buy, 68.75% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 11.76% Strong Buy, 58.82% Buy, 29.41% Hold, 0% Sell, 0% Strong Sell.
  • July 2025: 18.75% Strong Buy, 50.00% Buy, 31.25% Hold, 0% Sell, 0% Strong Sell.

What is Bio-Techne’s EPS forecast?

Bio-Techne's average annual EPS forecast for its fiscal year ending in June 2025 is $1.88, marking a 75.70% increase from the reported $1.07 in 2024. Estimates for the following years are $2.18 in 2026, $2.49 in 2027, and $0 in 2028.

What is Bio-Techne’s revenue forecast?

Bio-Techne's average annual revenue forecast for its fiscal year ending in June 2025 is $1.22B, reflecting a 5.28% increase from the reported $1.16B in 2024. The forecast for 2026 is $1.33B, followed by $1.48B for 2027, and $1.86B for 2028.

What is Bio-Techne’s net income forecast?

Bio-Techne's net income forecast for the fiscal year ending in June 2025 stands at $300.71M, representing an 78.88% increase from the reported $168.1M in 2024. Projections indicate $352.85M in 2026, $408.3M in 2027, and $0 in 2028.